참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Salicylamide | HCID 5147 | — |
| 반응물 | Sodium hydride | HCID 24758 | — |
| 반응물 | 5-Chloro-2-hydroxybenzamide | HCID 348094 | — |
| 반응물 | 3-Bromo-1-methylpyrrolidine | HCID 13726279 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | 5-Chloro-2-[(1-methyl-3-pyrrolidinyl)oxy]benzamide hemihydrate | HCID 70393698 | 34.1% |
반응 단계
To a cooled suspension of 2.4 g (0.41 mole) sodium hydride in 50 ml of dimethylformamide was added dropwise 17 g (0.1 mole) of 5-chlorosalicylamide dissolved in 50 ml of dimethylformamide at a rate such that the temperature did not exceed 20° C. After addition of the salicylamide was complete, 16.7 g (0.1 mole) of 3-bromo-1-methylpyrrolidine dissolved in 50 ml of dimethylformamide was added dropwise. The reaction mixture was stirred and heated at reflux for 19 hr. The cooled solution was diluted with 250 ml of water and extracted twice with 250 ml portions of chloroform. The chloroform was extracted thrice with 500 ml portions of 3N hydrochloric acid. The aqueous extracts were made alkaline with 50% sodium hydroxide and extracted with ethyl acetate. Drying over magnesium sulfate and evaporation of the ethyl acetate under reduced pressure gave 6 g (23%) of product as a beige solid. The solid was recrystallized from ethyl acetate, m.p. 126°-128° C.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04727152 |
|---|
| 출처 데이터셋 | uspto-grants-1988_02 |
|---|
| ORD ID | ord-cb8859507f564718bbce4716cd124083 |
|---|
| 출처 메모 | uspto-grants-1988_02 |
|---|